Annual CFI
-$936.20 K
+$5.52 M+85.50%
31 December 2023
Summary:
Cytosorbents annual cash flow from investing activities is currently -$936.20 thousand, with the most recent change of +$5.52 million (+85.50%) on 31 December 2023. During the last 3 years, it has risen by +$740.00 thousand (+44.15%). CTSO annual CFI is now -158.64% below its all-time high of $1.60 million, reached on 31 December 2016.CTSO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$298.40 K
-$178.50 K-148.87%
30 September 2024
Summary:
Cytosorbents quarterly cash flow from investing activities is currently -$298.40 thousand, with the most recent change of -$178.50 thousand (-148.87%) on 30 September 2024. Over the past year, it has dropped by -$40.70 thousand (-15.79%). CTSO quarterly CFI is now -105.72% below its all-time high of $5.21 million, reached on 31 December 2014.CTSO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$681.20 K
-$40.70 K-6.35%
30 September 2024
Summary:
Cytosorbents TTM cash flow from investing activities is currently -$681.20 thousand, with the most recent change of -$40.70 thousand (-6.35%) on 30 September 2024. Over the past year, it has increased by +$325.20 thousand (+32.31%). CTSO TTM CFI is now -114.22% below its all-time high of $4.79 million, reached on 30 September 2015.CTSO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTSO Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +85.5% | -15.8% | +32.3% |
| 3 y3 years | +44.1% | +70.7% | +76.3% |
| 5 y5 years | +38.4% | +5.4% | +52.7% |
CTSO Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +85.5% | -312.7% | +93.6% | -79.1% | +91.7% |
| 5 y | 5 years | at high | +85.5% | -312.7% | +93.6% | -79.1% | +91.7% |
| alltime | all time | -158.6% | +85.5% | -105.7% | +93.8% | -114.2% | +91.7% |
Cytosorbents Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$298.40 K(+148.9%) | -$681.20 K(+6.4%) |
| June 2024 | - | -$119.90 K(-5.6%) | -$640.50 K(+68.4%) |
| Mar 2024 | - | -$127.00 K(-6.5%) | -$380.30 K(-59.4%) |
| Dec 2023 | -$936.20 K(-85.5%) | -$135.90 K(-47.3%) | -$936.20 K(-7.0%) |
| Sept 2023 | - | -$257.70 K(-283.7%) | -$1.01 M(-31.3%) |
| June 2023 | - | $140.30 K(-120.5%) | -$1.47 M(-76.7%) |
| Mar 2023 | - | -$682.90 K(+231.3%) | -$6.29 M(-2.6%) |
| Dec 2022 | -$6.46 M(+50.8%) | -$206.10 K(-71.2%) | -$6.46 M(-18.5%) |
| Sept 2022 | - | -$716.50 K(-84.7%) | -$7.92 M(-3.7%) |
| June 2022 | - | -$4.68 M(+452.5%) | -$8.22 M(+81.8%) |
| Mar 2022 | - | -$848.00 K(-49.3%) | -$4.52 M(+5.6%) |
| Dec 2021 | -$4.28 M(+155.4%) | -$1.67 M(+64.4%) | -$4.28 M(+48.9%) |
| Sept 2021 | - | -$1.02 M(+3.3%) | -$2.87 M(+27.1%) |
| June 2021 | - | -$984.70 K(+62.4%) | -$2.26 M(+27.5%) |
| Mar 2021 | - | -$606.30 K(+127.8%) | -$1.77 M(+5.8%) |
| Dec 2020 | -$1.68 M(+10.3%) | -$266.10 K(-34.2%) | -$1.68 M(-7.6%) |
| Sept 2020 | - | -$404.20 K(-18.7%) | -$1.81 M(+5.1%) |
| June 2020 | - | -$497.40 K(-2.2%) | -$1.72 M(+10.9%) |
| Mar 2020 | - | -$508.60 K(+26.1%) | -$1.55 M(+2.3%) |
| Dec 2019 | -$1.52 M(-0.0%) | -$403.20 K(+27.8%) | -$1.52 M(+5.5%) |
| Sept 2019 | - | -$315.40 K(-3.6%) | -$1.44 M(+2.8%) |
| June 2019 | - | -$327.30 K(-31.0%) | -$1.40 M(-8.0%) |
| Mar 2019 | - | -$474.20 K(+46.6%) | -$1.52 M(+0.1%) |
| Dec 2018 | -$1.52 M(-9.4%) | -$323.40 K(+17.1%) | -$1.52 M(-14.5%) |
| Sept 2018 | - | -$276.20 K(-38.4%) | -$1.78 M(-12.9%) |
| June 2018 | - | -$448.40 K(-5.1%) | -$2.04 M(+4.9%) |
| Mar 2018 | - | -$472.30 K(-18.8%) | -$1.95 M(+16.0%) |
| Dec 2017 | -$1.68 M(-205.1%) | -$582.00 K(+7.9%) | -$1.68 M(+40.5%) |
| Sept 2017 | - | -$539.20 K(+53.0%) | -$1.19 M(+101.5%) |
| June 2017 | - | -$352.50 K(+72.4%) | -$592.80 K(-133.0%) |
| Mar 2017 | - | -$204.50 K(+108.2%) | $1.80 M(+12.6%) |
| Dec 2016 | $1.60 M(-279.2%) | -$98.20 K(-257.4%) | $1.60 M(+30.2%) |
| Sept 2016 | - | $62.40 K(-96.9%) | $1.23 M(-44.8%) |
| June 2016 | - | $2.04 M(-603.1%) | $2.22 M(-1478.9%) |
| Mar 2016 | - | -$404.90 K(-13.5%) | -$161.20 K(-81.9%) |
| Dec 2015 | -$890.90 K | -$468.20 K(-144.2%) | -$890.90 K(-118.6%) |
| Sept 2015 | - | $1.06 M(-405.3%) | $4.79 M(+348.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | - | -$346.80 K(-69.4%) | $1.07 M(-19.3%) |
| Mar 2015 | - | -$1.13 M(-121.8%) | $1.32 M(-157.3%) |
| Dec 2014 | -$2.31 M(+968.3%) | $5.21 M(-295.7%) | -$2.31 M(-69.9%) |
| Sept 2014 | - | -$2.66 M(+2841.3%) | -$7.69 M(+52.5%) |
| June 2014 | - | -$90.60 K(-98.1%) | -$5.04 M(+1.2%) |
| Mar 2014 | - | -$4.77 M(+2805.5%) | -$4.99 M(+2204.7%) |
| Dec 2013 | -$216.40 K(+457.7%) | -$164.20 K(+877.4%) | -$216.30 K(+209.4%) |
| Sept 2013 | - | -$16.80 K(-49.2%) | -$69.90 K(+45.6%) |
| June 2013 | - | -$33.10 K(+1404.5%) | -$48.00 K(+62.2%) |
| Mar 2013 | - | -$2200.00(-87.6%) | -$29.60 K(-23.5%) |
| Dec 2012 | -$38.80 K(-26.1%) | -$17.80 K(-449.0%) | -$38.70 K(+80.0%) |
| Sept 2012 | - | $5100.00(-134.7%) | -$21.50 K(-57.1%) |
| June 2012 | - | -$14.70 K(+30.1%) | -$50.10 K(-21.5%) |
| Mar 2012 | - | -$11.30 K(+1783.3%) | -$63.80 K(+21.5%) |
| Dec 2011 | -$52.50 K(-68.3%) | -$600.00(-97.4%) | -$52.50 K(-73.0%) |
| Sept 2011 | - | -$23.50 K(-17.3%) | -$194.30 K(+9.0%) |
| June 2011 | - | -$28.40 K(<-9900.0%) | -$178.30 K(+7.8%) |
| Mar 2011 | - | $0.00(-100.0%) | -$165.40 K(0.0%) |
| Dec 2010 | -$165.40 K(-189.3%) | -$142.40 K(+1798.7%) | -$165.40 K(+595.0%) |
| Sept 2010 | - | -$7500.00(-51.6%) | -$23.80 K(+46.0%) |
| June 2010 | - | -$15.50 K(+1837.5%) | -$16.30 K(-108.8%) |
| Dec 2009 | $185.30 K(-183.6%) | -$800.00(<-9900.0%) | $185.20 K(-941.8%) |
| Sept 2009 | - | $0.00(-100.0%) | -$22.00 K(-14.7%) |
| June 2009 | - | -$3700.00(-102.0%) | -$25.80 K(-4.4%) |
| Mar 2009 | - | $189.70 K(-191.2%) | -$27.00 K(-87.8%) |
| Dec 2008 | -$221.70 K(+557.9%) | -$208.00 K(+5373.7%) | -$221.70 K(+1518.2%) |
| Sept 2008 | - | -$3800.00(-22.4%) | -$13.70 K(+38.4%) |
| June 2008 | - | -$4900.00(-2.0%) | -$9900.00(+52.3%) |
| Mar 2008 | - | -$5000.00(<-9900.0%) | -$6500.00(-80.7%) |
| Dec 2007 | -$33.70 K(-48.1%) | $0.00(0.0%) | -$33.70 K(0.0%) |
| Sept 2007 | - | $0.00(-100.0%) | -$33.70 K(0.0%) |
| June 2007 | - | -$1500.00(-95.3%) | -$33.70 K(+4.7%) |
| Mar 2007 | - | -$32.20 K(>+9900.0%) | -$32.20 K(+1300.0%) |
| Dec 2006 | -$64.90 K | - | - |
| Feb 2006 | - | -$300.00(-130.0%) | -$2300.00(+15.0%) |
| Nov 2005 | - | $1000.00(-133.3%) | -$2000.00(-33.3%) |
| Aug 2005 | - | -$3000.00 | -$3000.00 |
FAQ
- What is Cytosorbents annual cash flow from investing activities?
- What is the all time high annual CFI for Cytosorbents?
- What is Cytosorbents annual CFI year-on-year change?
- What is Cytosorbents quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Cytosorbents?
- What is Cytosorbents quarterly CFI year-on-year change?
- What is Cytosorbents TTM cash flow from investing activities?
- What is the all time high TTM CFI for Cytosorbents?
- What is Cytosorbents TTM CFI year-on-year change?
What is Cytosorbents annual cash flow from investing activities?
The current annual CFI of CTSO is -$936.20 K
What is the all time high annual CFI for Cytosorbents?
Cytosorbents all-time high annual cash flow from investing activities is $1.60 M
What is Cytosorbents annual CFI year-on-year change?
Over the past year, CTSO annual cash flow from investing activities has changed by +$5.52 M (+85.50%)
What is Cytosorbents quarterly cash flow from investing activities?
The current quarterly CFI of CTSO is -$298.40 K
What is the all time high quarterly CFI for Cytosorbents?
Cytosorbents all-time high quarterly cash flow from investing activities is $5.21 M
What is Cytosorbents quarterly CFI year-on-year change?
Over the past year, CTSO quarterly cash flow from investing activities has changed by -$40.70 K (-15.79%)
What is Cytosorbents TTM cash flow from investing activities?
The current TTM CFI of CTSO is -$681.20 K
What is the all time high TTM CFI for Cytosorbents?
Cytosorbents all-time high TTM cash flow from investing activities is $4.79 M
What is Cytosorbents TTM CFI year-on-year change?
Over the past year, CTSO TTM cash flow from investing activities has changed by +$325.20 K (+32.31%)